iCAD to Join Forces with Radiology Partners, the Nation’s Largest Radiology Practice

Strategic commercial agreement in development will leverage Radiology Partners’ clinical expertise, ability to scale and leadership position to drive nationwide adoption of iCAD’s Breast AI Suite

 iCAD, , a global medical technology leader providing innovative cancer detection and therapy solutions, announced the first step in the development of a new strategic multi-year commercial agreement and an initial order with Radiology Partners, the largest radiology practice in the U.S. This planned collaboration will solidify iCAD’s position as Radiology Partners’ provider of breast AI solutions and will leverage Radiology Partners’ clinical expertise, scale and leadership position to expand access to iCAD’s Breast AI Suite to thousands of physicians and millions of patients.

AI News: AI’s Role in Job Search and Job Marketing

“As we continue to deliver on our mission to elevate the quality of breast cancer screening, the expected execution of a collaboration agreement will mark a key step forward in our ability to provide access to our unparalleled portfolio to significantly more radiologists, practices and patients nationwide,” said Stacey Stevens, President and CEO of iCAD, Inc. “Nationally recognized for their clinical leadership in mammography screening, Radiology Partners provides mammography services to millions of women per year across more than 3,000 facilities, including the top ten largest health systems in the country, making them an exceptional partner. This partnership will mark a tremendous milestone achievement for iCAD and will represent an exciting opportunity to aggressively expand access to our technology to more women.”

The company has already received its first order from Radiology Partners, allowing hundreds of thousands of women to be screened at Radiology Partners’ owned outpatient imaging center sites with iCAD’s Breast AI Suite. iCAD’s technology can be deployed to the Radiology Partners network via the Radiology Partners Cloud, significantly increasing the potential for adoption across their network of facilities and unleashing the ability to improve mammography screening for millions of women across the country.

iCAD’s Breast AI Suite is the only complete portfolio of first-in-kind, clinically proven technologies for the detection of breast cancer, automated breast density assessment and short-term personal risk evaluation. The portfolio includes: ProFound AI^®, the first AI cancer detection software for 3D mammography to be cleared by the FDA; PowerLook^® Breast Density Assessment, which aids in accurate and consistent density-based stratification and reporting; and ProFound AI^® Risk, the world’s first and only clinical decision support tool that provides an accurate short-term, breast cancer risk estimation that is truly personalized for each woman based on age, breast density and mammographic features.

Latest NaturalAI Insights: InspireXT Announces Acquisition Of NaturalAI – A Conversational Artificial Intelligence Platform To Expand Its Solution Portfolio

“As the largest and leading radiology practice in the U.S., it is important to identify partners that can work with us to deploy and integrate AI at scale as we advance our mission to transform radiology,” said Rich Whitney, Radiology Partners Chairman and CEO. “iCAD’s Breast AI Suite will allow us to equip our radiologists with tools to continually elevate our breast screening practices, which in turn strengthens our ability to provide quality care and excellent service to the women and families we serve across the U.S.”

“At Radiology Partners, we believe technological innovations are transforming the practice of radiology, and we are focused on leveraging AI to create the world’s leading imaging enterprise,” said Dr. Nina Kottler, Radiology Partners Associate CMO for Clinical Artificial Intelligence. “In our search for a breast AI solution, we were looking for a partner—not a product–and iCAD excels in this respect. In addition to their portfolio of unrivaled AI technologies, we share a commitment to advance the use of AI to become standard of care in mammography screening, and we are proud to partner with them in the fight against breast cancer.”

“In addition to transforming mammography screening nationwide, Radiology Partners and iCAD have an opportunity to leverage each other’s strengths to address some of the toughest challenges facing radiology today. As we move ahead, we look forward to realizing the mutually meaningful growth this partnership could represent,” added Ms. Stevens.

Latest Aithority Insights : NVIDIA Raises the Standard of Low Code DevOps with the NVIDIA AI Enterprise 2.1

 [To share your insights with us, please write to sghosh@martechseries.com]